Clinical trials

  • SAR447754 for Atopic dermatitis
  • PUMITAMIG for Non-small cell lung cancer
  • Ibutamoren mesylate for Growth hormone deficiency (GHD)
  • REGN22044 for Healthy volunteer
  • Ketamine for Healthy volunteers
  • AIR-001 for Alpha-1 antitrypsin deficiency
  • GLOFITAMAB for Relapsed/refractory diffuse large B-cell lymphoma
  • NAV-240 for Moderate-to-severe Hidradenitis suppurativa
  • ZENAGAMTIDE for Obesity
  • BG-75202 for Advanced and metastatic solid tumors | Hormone receptor-positive HER2-negative breast cancer | Castration-resistant prostate cancer | Metastatic triple-negative breast cancer
  • AZD0120 for Relapsed or refractory multiple myeloma
  • GUSELKUMAB for Psoriatic arthritis|Psoriasis